Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Holding AKRO?
Track your performance easily

Akero Therapeutics (AKRO) Financial Statements

456 Followers

Akero Therapeutics Financial Overview

Akero Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.412; its P/E ratio is -7.90; Akero Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -54.76M$ -52.35M$ -54.29M$ -39.03M$ -30.50M
EBITDA$ -51.68M$ -52.35M$ -54.29M$ -42.17M$ -31.75M
Net Income Common Stockholders$ -55.99M$ -53.34M$ -55.19M$ -39.91M$ -31.08M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 760.19M$ 903.66M$ 550.01M$ 554.73M$ 639.44M
Total Assets$ 865.04M$ 912.24M$ 580.27M$ 635.33M$ 663.81M
Total Debt$ 35.64M$ 35.55M$ 25.78M$ 25.73M$ 25.68M
Net Debt$ -724.56M$ -868.11M$ -524.23M$ -529.00M$ -613.76M
Total Liabilities$ 66.98M$ 65.99M$ 44.97M$ 52.20M$ 47.37M
Stockholders Equity$ 798.07M$ 846.25M$ 535.31M$ 583.13M$ 616.44M
Cash Flow-
Free Cash Flow$ -57.45M$ -35.14M$ -48.63M$ -49.72M$ -22.39M
Operating Cash Flow$ -57.45M$ -35.14M$ -48.63M$ -49.72M$ -22.39M
Investing Cash Flow$ -255.90M$ 57.85M$ 12.79M$ -125.70M$ -128.30M
Financing Cash Flow$ -150.00K$ 366.94M$ 502.00K$ 806.00K$ 336.86M
Currency in USD

Akero Therapeutics Earnings and Revenue History

Akero Therapeutics Debt to Assets

Akero Therapeutics Cash Flow

Akero Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis